SUVRETTA CAPITAL MANAGEMENT, LLC 13D and 13G filings for KalVista Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 3:57 pm Purchase |
2024-09-30 | 13G | KalVista Pharmaceuticals, Inc. KALV |
SUVRETTA CAPITAL MANAGEMENT, LLC | 4,328,904 9.990% |
1,644,899 (+61.29%) |
Filing |
| 2024-02-13 5:19 pm Purchase |
2023-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,684,005 7.800% |
887,626 (+49.41%) |
Filing |
| 2023-03-10 5:15 pm Purchase |
2023-01-25 | 13G | KalVista Pharmaceuticals, Inc. KALV |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,796,379 5.300% |
724,077 (+67.53%) |
Filing |
| 2023-02-13 10:51 am Sale |
2022-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,072,302 3.100% |
-673,998 (-38.60%) |
Filing |
| 2022-02-11 5:03 pm Purchase |
2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,746,300 7.100% |
449,848 (+34.70%) |
Filing |
| 2021-09-17 4:54 pm Purchase |
2021-09-07 | 13G | KalVista Pharmaceuticals, Inc. KALV |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,296,452 5.300% |
1,296,452 (New Position) |
Filing |